Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

Researchers have found that for high bleeding risk individuals, one month of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with biodegradable-polymer sirolimus-eluting...
Empagliflozin Provides Long-Awaited Treatment for HFpEF

EMPEROR’s New Groove? Empagliflozin Provides Long-Awaited Treatment for HFpEF

Empagliflozin, a sodium glucose co-transporter 2 inhibitor (SGLT2i), significantly reduced the composite endpoint of heart failure (HF) hospitalization and cardiovascular death in patients with...
Moderate Alcohol Drinking Can Have Effects on Heart Size

Moderate Alcohol Drinking Can Have Effects on Heart Size

Heavy alcohol drinking leading to dilated cardiomyopathy is a well-known entity1 but are there cardiac ramifications to consumption of just moderate amounts of alcohol...
DoReMi: SO FAr, No Difference in Outcomes Between Milrinone and Dobutamine in Cardiogenic Shock

DoReMi: SO FAr, No Difference in Outcomes Between Milrinone and Dobutamine in Cardiogenic Shock

In a recent randomized clinical trial published in the New England Journal of Medicine on August 5, 2021, Dr. Rebecca Mathew et al. found...
Advertisement
Advertisement